These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

596 related articles for article (PubMed ID: 29524051)

  • 1. Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.
    Lin L; Zheng LJ; Zhang LJ
    Mol Neurobiol; 2018 Nov; 55(11):8243-8250. PubMed ID: 29524051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease.
    Elmaleh DR; Downey MA; Kundakovic L; Wilkinson JE; Neeman Z; Segal E
    J Alzheimers Dis; 2021; 82(4):1373-1401. PubMed ID: 34219718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    Sun M; Ma K; Wen J; Wang G; Zhang C; Li Q; Bao X; Wang H
    J Alzheimers Dis; 2020; 73(3):849-865. PubMed ID: 31884474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunopathogenesis of Alzheimer's Disease Is Related to the Composition of Gut Microbiota.
    Leblhuber F; Ehrlich D; Steiner K; Geisler S; Fuchs D; Lanser L; Kurz K
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33504065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to test antibacterial therapy in Alzheimer's disease.
    Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
    Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
    Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
    mBio; 2019 May; 10(3):. PubMed ID: 31064831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiota Alterations in Alzheimer's Disease: Involvement of the Kynurenine Pathway and Inflammation.
    Garcez ML; Jacobs KR; Guillemin GJ
    Neurotox Res; 2019 Aug; 36(2):424-436. PubMed ID: 31089885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gut microbiota in pathogenesis of Alzheimer's disease.
    Bostanciklioğlu M
    J Appl Microbiol; 2019 Oct; 127(4):954-967. PubMed ID: 30920075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Gut Microbiota and Alzheimer's Disease.
    Jiang C; Li G; Huang P; Liu Z; Zhao B
    J Alzheimers Dis; 2017; 58(1):1-15. PubMed ID: 28372330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Muscle-Gut-Brain Axis": Can Physical Activity Help Patients with Alzheimer's Disease Due to Microbiome Modulation?
    Schlegel P; Novotny M; Klimova B; Valis M
    J Alzheimers Dis; 2019; 71(3):861-878. PubMed ID: 31476155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Gut Microbiota and Central Nervous System: A Focus on Alzheimer's Disease.
    Junges VM; Closs VE; Nogueira GM; Gottlieb MGV
    Curr Alzheimer Res; 2018; 15(13):1179-1190. PubMed ID: 30182854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions.
    Solas M; Milagro FI; Ramírez MJ; Martínez JA
    Curr Opin Pharmacol; 2017 Dec; 37():87-92. PubMed ID: 29107872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease.
    Bonfili L; Cecarini V; Gogoi O; Gong C; Cuccioloni M; Angeletti M; Rossi G; Eleuteri AM
    FEBS J; 2021 May; 288(9):2836-2855. PubMed ID: 32969566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Gut Microbiota to Brain Waves: The Potential of the Microbiome and EEG as Biomarkers for Cognitive Impairment.
    Krothapalli M; Buddendorff L; Yadav H; Schilaty ND; Jain S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards understanding brain-gut-microbiome connections in Alzheimer's disease.
    Xu R; Wang Q
    BMC Syst Biol; 2016 Aug; 10 Suppl 3(Suppl 3):63. PubMed ID: 27585440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Gut Microbiome Composition and Tryptic Activity of the 5xFAD Alzheimer's Mouse Model.
    Brandscheid C; Schuck F; Reinhardt S; Schäfer KH; Pietrzik CU; Grimm M; Hartmann T; Schwiertz A; Endres K
    J Alzheimers Dis; 2017; 56(2):775-788. PubMed ID: 28035935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer's disease during lifespan.
    Bäuerl C; Collado MC; Diaz Cuevas A; Viña J; Pérez Martínez G
    Lett Appl Microbiol; 2018 Jun; 66(6):464-471. PubMed ID: 29575030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer's Disease.
    Giau VV; Wu SY; Jamerlan A; An SSA; Kim SY; Hulme J
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30441866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.